 | • レポートコード：MRC2012A4680 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ヒトワクチンアジュバントの世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒトワクチンアジュバントの種類別市場規模（経口、皮下、筋肉内、その他）、用途別市場規模（研究、商用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Aphios、SEPPIC、CSL Limited、Avanti Polar Lipids、Brenntag Biosector、Novavax、SPI Pharma、 ・地域別グローバル市場分析 2015年-2020年 ・ヒトワクチンアジュバントの北米市場（アメリカ、カナダ、メキシコ） ・ヒトワクチンアジュバントのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ヒトワクチンアジュバントのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ヒトワクチンアジュバントの南米市場（ブラジル、アルゼンチン） ・ヒトワクチンアジュバントの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、皮下、筋肉内、その他 ・用途別分析：研究、商用 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Human Vaccine Adjuvants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Human Vaccine Adjuvants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Human Vaccine Adjuvants market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Human Vaccine Adjuvants market has been segmented into
Oral
Subcutaneous
Intramuscular
Others
By Application, Human Vaccine Adjuvants has been segmented into:
Research Applications
Commercial Applications
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Vaccine Adjuvants market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Vaccine Adjuvants markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Vaccine Adjuvants market.
The report offers in-depth assessment of the growth and other aspects of the Human Vaccine Adjuvants market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Human Vaccine Adjuvants Market Share Analysis
Human Vaccine Adjuvants competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Vaccine Adjuvants sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Vaccine Adjuvants sales, revenue and market share for each player covered in this report.
The major players covered in Human Vaccine Adjuvants are:
GSK
Aphios
SEPPIC
CSL Limited
Avanti Polar Lipids
Brenntag Biosector
Novavax
SPI Pharma
Among other players domestic and global, Human Vaccine Adjuvants market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Vaccine Adjuvants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Vaccine Adjuvants, with price, sales, revenue and global market share of Human Vaccine Adjuvants in 2018 and 2019.
Chapter 3, the Human Vaccine Adjuvants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Human Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Human Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Human Vaccine Adjuvants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Vaccine Adjuvants Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Vaccine Adjuvants Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research Applications
1.3.3 Commercial Applications
1.4 Overview of Global Human Vaccine Adjuvants Market
1.4.1 Global Human Vaccine Adjuvants Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Aphios
2.2.1 Aphios Details
2.2.2 Aphios Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Aphios SWOT Analysis
2.2.4 Aphios Product and Services
2.2.5 Aphios Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 SEPPIC
2.3.1 SEPPIC Details
2.3.2 SEPPIC Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 SEPPIC SWOT Analysis
2.3.4 SEPPIC Product and Services
2.3.5 SEPPIC Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CSL Limited
2.4.1 CSL Limited Details
2.4.2 CSL Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CSL Limited SWOT Analysis
2.4.4 CSL Limited Product and Services
2.4.5 CSL Limited Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Avanti Polar Lipids
2.5.1 Avanti Polar Lipids Details
2.5.2 Avanti Polar Lipids Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Avanti Polar Lipids SWOT Analysis
2.5.4 Avanti Polar Lipids Product and Services
2.5.5 Avanti Polar Lipids Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Brenntag Biosector
2.6.1 Brenntag Biosector Details
2.6.2 Brenntag Biosector Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Brenntag Biosector SWOT Analysis
2.6.4 Brenntag Biosector Product and Services
2.6.5 Brenntag Biosector Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novavax
2.7.1 Novavax Details
2.7.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novavax SWOT Analysis
2.7.4 Novavax Product and Services
2.7.5 Novavax Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 SPI Pharma
2.8.1 SPI Pharma Details
2.8.2 SPI Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 SPI Pharma SWOT Analysis
2.8.4 SPI Pharma Product and Services
2.8.5 SPI Pharma Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human Vaccine Adjuvants Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human Vaccine Adjuvants Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Vaccine Adjuvants Manufacturer Market Share in 2019
3.3.2 Top 6 Human Vaccine Adjuvants Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human Vaccine Adjuvants Sales, Revenue and Market Share by Regions
4.1.1 Global Human Vaccine Adjuvants Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Vaccine Adjuvants Revenue and Market Share by Regions (2015-2020)
4.2 North America Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
4.3 Europe Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
4.5 South America Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human Vaccine Adjuvants Sales, Revenue and Market Share by Country
5.1.1 North America Human Vaccine Adjuvants Sales and Market Share by Country (2015-2020)
5.1.2 North America Human Vaccine Adjuvants Revenue and Market Share by Country (2015-2020)
5.2 United States Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
5.3 Canada Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
5.4 Mexico Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human Vaccine Adjuvants Sales, Revenue and Market Share by Country
6.1.1 Europe Human Vaccine Adjuvants Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human Vaccine Adjuvants Revenue and Market Share by Country (2015-2020)
6.2 Germany Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
6.3 UK Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
6.4 France Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
6.5 Russia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
6.6 Italy Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human Vaccine Adjuvants Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human Vaccine Adjuvants Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human Vaccine Adjuvants Revenue and Market Share by Regions (2015-2020)
7.2 China Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7.3 Japan Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7.4 Korea Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7.5 India Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7.7 Australia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human Vaccine Adjuvants Sales, Revenue and Market Share by Country
8.1.1 South America Human Vaccine Adjuvants Sales and Market Share by Country (2015-2020)
8.1.2 South America Human Vaccine Adjuvants Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
8.3 Argentina Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human Vaccine Adjuvants Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human Vaccine Adjuvants Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human Vaccine Adjuvants Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
9.3 Turkey Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
9.4 Egypt Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
9.5 South Africa Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human Vaccine Adjuvants Sales and Market Share by Type (2015-2020)
10.2 Global Human Vaccine Adjuvants Revenue and Market Share by Type (2015-2020)
10.3 Global Human Vaccine Adjuvants Price by Type (2015-2020)
11 Global Human Vaccine Adjuvants Market Segment by Application
11.1 Global Human Vaccine Adjuvants Sales Market Share by Application (2015-2020)
11.2 Global Human Vaccine Adjuvants Revenue Market Share by Application (2015-2020)
11.3 Global Human Vaccine Adjuvants Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human Vaccine Adjuvants Sales, Revenue and Growth Rate (2021-2025)
12.2 Human Vaccine Adjuvants Market Forecast by Regions (2021-2025)
12.2.1 North America Human Vaccine Adjuvants Market Forecast (2021-2025)
12.2.2 Europe Human Vaccine Adjuvants Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human Vaccine Adjuvants Market Forecast (2021-2025)
12.2.4 South America Human Vaccine Adjuvants Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human Vaccine Adjuvants Market Forecast (2021-2025)
12.3 Human Vaccine Adjuvants Market Forecast by Type (2021-2025)
12.3.1 Global Human Vaccine Adjuvants Sales Forecast by Type (2021-2025)
12.3.2 Global Human Vaccine Adjuvants Market Share Forecast by Type (2021-2025)
12.4 Human Vaccine Adjuvants Market Forecast by Application (2021-2025)
12.4.1 Global Human Vaccine Adjuvants Sales Forecast by Application (2021-2025)
12.4.2 Global Human Vaccine Adjuvants Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Human Vaccine Adjuvants Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Vaccine Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Vaccine Adjuvants Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Human Vaccine Adjuvants Major Business
Table 9. GSK Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 10. GSK SWOT Analysis
Table 11. GSK Human Vaccine Adjuvants Product and Services
Table 12. GSK Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Aphios Basic Information, Manufacturing Base and Competitors
Table 14. Aphios Human Vaccine Adjuvants Major Business
Table 15. Aphios Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 16. Aphios SWOT Analysis
Table 17. Aphios Human Vaccine Adjuvants Product and Services
Table 18. Aphios Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. SEPPIC Basic Information, Manufacturing Base and Competitors
Table 20. SEPPIC Human Vaccine Adjuvants Major Business
Table 21. SEPPIC Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 22. SEPPIC SWOT Analysis
Table 23. SEPPIC Human Vaccine Adjuvants Product and Services
Table 24. SEPPIC Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 26. CSL Limited Human Vaccine Adjuvants Major Business
Table 27. CSL Limited Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 28. CSL Limited SWOT Analysis
Table 29. CSL Limited Human Vaccine Adjuvants Product and Services
Table 30. CSL Limited Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
Table 32. Avanti Polar Lipids Human Vaccine Adjuvants Major Business
Table 33. Avanti Polar Lipids Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 34. Avanti Polar Lipids SWOT Analysis
Table 35. Avanti Polar Lipids Human Vaccine Adjuvants Product and Services
Table 36. Avanti Polar Lipids Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Brenntag Biosector Basic Information, Manufacturing Base and Competitors
Table 38. Brenntag Biosector Human Vaccine Adjuvants Major Business
Table 39. Brenntag Biosector Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 40. Brenntag Biosector SWOT Analysis
Table 41. Brenntag Biosector Human Vaccine Adjuvants Product and Services
Table 42. Brenntag Biosector Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novavax Basic Information, Manufacturing Base and Competitors
Table 44. Novavax Human Vaccine Adjuvants Major Business
Table 45. Novavax Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 46. Novavax SWOT Analysis
Table 47. Novavax Human Vaccine Adjuvants Product and Services
Table 48. Novavax Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. SPI Pharma Basic Information, Manufacturing Base and Competitors
Table 50. SPI Pharma Human Vaccine Adjuvants Major Business
Table 51. SPI Pharma Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 52. SPI Pharma SWOT Analysis
Table 53. SPI Pharma Human Vaccine Adjuvants Product and Services
Table 54. SPI Pharma Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Human Vaccine Adjuvants Sales by Manufacturer (2018-2019) (MT)
Table 56. Global Human Vaccine Adjuvants Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Human Vaccine Adjuvants Sales by Regions (2015-2020) (MT)
Table 58. Global Human Vaccine Adjuvants Sales Market Share by Regions (2015-2020)
Table 59. Global Human Vaccine Adjuvants Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Human Vaccine Adjuvants Sales by Countries (2015-2020) (MT)
Table 61. North America Human Vaccine Adjuvants Sales Market Share by Countries (2015-2020)
Table 62. North America Human Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020)
Table 64. Europe Human Vaccine Adjuvants Sales by Countries (2015-2020) (MT)
Table 65. Europe Human Vaccine Adjuvants Sales Market Share by Countries (2015-2020)
Table 66. Europe Human Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Human Vaccine Adjuvants Sales by Regions (2015-2020) (MT)
Table 68. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Human Vaccine Adjuvants Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Human Vaccine Adjuvants Sales by Countries (2015-2020) (MT)
Table 71. South America Human Vaccine Adjuvants Sales Market Share by Countries (2015-2020)
Table 72. South America Human Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Human Vaccine Adjuvants Sales by Countries (2015-2020) (MT)
Table 75. Middle East & Africa Human Vaccine Adjuvants Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Human Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020)
Table 78. Global Human Vaccine Adjuvants Sales by Type (2015-2020) (MT)
Table 79. Global Human Vaccine Adjuvants Sales Share by Type (2015-2020)
Table 80. Global Human Vaccine Adjuvants Revenue by Type (2015-2020) (USD Million)
Table 81. Global Human Vaccine Adjuvants Revenue Share by Type (2015-2020)
Table 82. Global Human Vaccine Adjuvants Sales by Application (2015-2020) (MT)
Table 83. Global Human Vaccine Adjuvants Sales Share by Application (2015-2020)
Table 84. Global Human Vaccine Adjuvants Sales Forecast by Regions (2021-2025) (MT)
Table 85. Global Human Vaccine Adjuvants Market Share Forecast by Regions (2021-2025)
Table 86. Global Human Vaccine Adjuvants Sales Forecast by Type (2021-2025) (MT)
Table 87. Global Human Vaccine Adjuvants Market Share Forecast by Type (2021-2025)
Table 88. Global Human Vaccine Adjuvants Sales Forecast by Application (2021-2025)
Table 89. Global Human Vaccine Adjuvants Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Human Vaccine Adjuvants Picture
Figure 2. Global Sales Market Share of Human Vaccine Adjuvants by Type in 2019
Figure 3. Oral Picture
Figure 4. Subcutaneous Picture
Figure 5. Intramuscular Picture
Figure 6. Others Picture
Figure 7. Human Vaccine Adjuvants Sales Market Share by Application in 2018
Figure 8. Research Applications Picture
Figure 9. Commercial Applications Picture
Figure 10. Global Human Vaccine Adjuvants Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Human Vaccine Adjuvants Sales Market Share by Manufacturer in 2019
Figure 31. Global Human Vaccine Adjuvants Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Human Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Human Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Human Vaccine Adjuvants Revenue Market Share by Regions (2015-2020)
Figure 38. Global Human Vaccine Adjuvants Revenue Market Share by Regions in 2018
Figure 39. North America Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
Figure 40. Europe Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
Figure 42. South America Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Human Vaccine Adjuvants Sales and Growth Rate (2015-2020)
Figure 44. North America Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Human Vaccine Adjuvants Sales Market Share by Countries (2015-2020)
Figure 46. North America Human Vaccine Adjuvants Sales Market Share by Countries in 2018
Figure 47. North America Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Human Vaccine Adjuvants Revenue Market Share by Countries in 2018
Figure 49. United States Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Human Vaccine Adjuvants Revenue Market Share by Countries in 2019
Figure 55. Germany Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 57. France Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Human Vaccine Adjuvants Revenue Market Share by Regions 2019
Figure 63. China Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 66. India Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Human Vaccine Adjuvants Sales Market Share by Countries in 2019
Figure 70. South America Human Vaccine Adjuvants Revenue Market Share by Countries in 2019
Figure 71. Brazil Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Human Vaccine Adjuvants Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Human Vaccine Adjuvants Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global Human Vaccine Adjuvants Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global Human Vaccine Adjuvants Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Human Vaccine Adjuvants Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales Human Vaccine Adjuvants Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales Human Vaccine Adjuvants Market Forecast (2021-2025) (MT)
Figure 86. South America Sales Human Vaccine Adjuvants Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales Human Vaccine Adjuvants Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
獣医用ワクチンアジュバントの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Veterinary Vaccine Adjuvants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- ヒトロタウイルスワクチンの世界市場（～2026年） Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two …
- ヒト用狂犬病ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Rabies Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Rabies Vaccine mar…
- ヒト狂犬病ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Human Rabies Vaccine Market The global Human Rabies Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Rabies Vaccine Scope and Market Size Human Rabies Vaccine market is…
- ヒトパピローマウイルスワクチンの世界市場（～2026年） Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus. Market Analysis and Insights: Global Human Papillomavirus Vaccine Market The global Human Papillomavirus Vaccine market size is projected to reach US$ 2220.7 million by 2026, from US$ 2…